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Dimerization or oligomerization of ATP synthase has been proposed to play an important role for mitochondrial cristae formation and to be
involved in regulating ATP synthase activity. We found comparable oligomycin-sensitive ATPase activity for monomeric and oligomeric ATP
synthase suggesting that oligomerization/monomerization dynamics are not directly involved in regulating ATP synthase activity. Binding of the
natural IF1 inhibitor protein has been shown to induce dimerization of F1-subcomplexes. This suggested that binding of IF1 might also dimerize
holo ATP synthase, and possibly link dimerization and inhibition. Analyzing mitochondria of human rho zero cells that contain mitochondria but
lack mitochondrial DNA, we identified three subcomplexes of ATP synthase: (i) F1 catalytic domain, (ii) F1-domain with bound IF1, and (iii) F1-c
subcomplex with bound IF1 and a ring of subunits c. Since both IF1 containing subcomplexes were present in monomeric state and exhibited
considerably reduced ATPase activity as compared to the third subcomplex lacking IF1, we postulate that inhibition and induction of dimerization
of F1-subcomplexes by IF1 are independent events. F1-subcomplexes were also found in mitochondria of patients with specific mitochondrial
disorders, and turned out to be useful for the clinical differentiation between various types of mitochondrial biosynthesis disorders.
Supramolecular associations of respiratory complexes, the “respirasomes”, seem not to be the largest assemblies in the structural organization of
the respiratory chain, as suggested by differential solubilization of mitochondria and electron microscopic analyses of whole mitochondria. We
present a model for a higher supramolecular association of respirasomes into a “respiratory string”.
© 2006 Elsevier B.V. All rights reserved.Keywords: Dimeric ATP synthase; Oligomeric ATP synthase; Supercomplex; Supramolecular organization; Respiratory chain; Respirasome1. Introduction
F1FO-ATP synthase, also named mitochondrial complex V,
often is described as an assembly of two major building blocks, a
hydrophobic FO part and a hydrophilic F1 subcomplex where
synthesis of ATP from ADP and phosphate takes place. Pio-
neering electron microscopic analyses of Paramecium multi-
micronucleatum mitochondria performed in 1989 by Richard D.
Allen et al. [1] identified in tubular cristae of the inner mito-
chondrial membrane “F1 complexes that are arranged as a double
row of particles”. In the light of present day knowledge this
supramolecular structure can be interpreted as a helix formed
from dimeric ATP synthase building blocks. Some years later,
Allen [2] presented a model for membrane tubulation by su-⁎ Corresponding author. Tel.: +49 69 63016933; fax: +49 69 63016970.
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doi:10.1016/j.bbabio.2006.05.006pramolecular association of proton pumps (F- and V-ATPases)
starting with a lateral association of single complexes, i.e. with
formation of dimeric ATP synthase. Further association of di-
meric ATP synthase into tilted helical structures would then form
a rigid arc that protrudes from the planar membrane surface
carrying the membrane with it and thus would initiate formation
of tubular cristae. If this nucleation process of ATP synthase
association was under the control of some unknown inducing
factor, cristae formation of the mitochondrial inner membrane
might in turn be used for regulating metabolic activity of mito-
chondria. Because oxidative phosphorylation relies on rapid dif-
fusion of ions and substrates to sites of transport or reaction in the
inner mitochondrial membrane, the number and shape of the
contacts of the cristae with the intermembrane space (cristae
junctions), could regulate ATP synthesis [2,3].
Some years later, in 1998, when dimeric yeast mitochondrial
ATP synthase containing three dimer-specific subunits was
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chondrial bioenergetics and ATP synthase apparently were not
aware of the observations by Allen and coworkers [1,2], as
reflected in the initial skepticism about the dimeric state of ATP
synthase. Therefore, important issues relating to the supramo-
lecular organization of ATP synthase have not been addressed
or answered so far: Is yeast and mammalian ATP synthase or-
ganized in higher oligomeric structures like in Paramecium
mitochondria? Which proteins can be found in the monomer/
monomer and dimer/dimer interfaces of dimeric and oligomeric
ATP synthase, respectively? Can dimerization/oligomerization of
ATP synthase immediately affect the catalytic activity of ATP
synthase or do these structural changes indirectly affect the
metabolic state of cells, e.g. by controlling cristae formation or by
conferring stability to the ATP synthase enzyme? Does binding of
the natural inhibitor proteins of ATP synthase, INH1 in yeast and
the homologous IF1 in mammalian mitochondria, induce
dimerization of holo ATP synthase, similar to the experimentally
verified dimerization of bovine F1-subcomplexes by IF1? Does
inhibition correlate with dimerization of F1-subcomplexes and
ATP synthase?
Finally, the pioneering work of Allen et al. [1] can stimulate
further research on the supramolecular organization of respiratory
chain complexes, since two different types of helical bands or
strings winding around tubular cristae have been observed. The
first helical band clearly contains a double row of F1-particles as
described above but what is the identity of the considerably larger
particles seen in the second helical string that might contain
dimeric complex I as suggested by Allen? Recent evidence sup-
ports the view that the second helical string, the “respiratory string”,
contains respiratory supercomplexes in regular intervals.
2. Dimeric and oligomeric mitochondrial ATP synthase
2.1. Isolation of dimeric and oligomeric ATP synthase
Dimeric ATP synthase has been isolated from various sources
including mitochondria from mammalia, algae, higher plants [4–
8], and also from chloroplast membranes of Chlamydomonas re-
inhardtii [9]. ATP synthase from Chlamydomonas reinhardtii mi-
tochondria is especially detergent-stable. It has been isolated as a
stable dimer in the presence of the detergent dodecylmaltoside [8].
No monomeric form has been identified. In contrast, the associate
of twomonomers is rather detergent-sensitive inmost other species
but often the dimeric state could be retained by using one of the
mildest detergents for membrane solubilization, namely digitonin
[5], or by applying low amounts of othermild detergents like Triton
X-100 [4]. In principle, these solubilization conditions can be used
in combination with conventional protein separation techniques
like size exclusion chromatography or ultracentrifugation but the
resolution of these separation techniques is poor for large mem-
brane protein complexes. Therefore, blue-native PAGE (BN-PAGE
[10,11]), a high resolution electrophoretic technique, has been
preferentially applied. This technique uses negatively charged
Coomassie-dye which binds to hydrophobic surface areas of
solubilized membrane proteins. The imposed negative charge
pulls the proteins to the anode during electrophoresis irrespec-tive of the proteins' intrinsic isoelectric point. In some cases,
minor amounts of ATP synthase forms larger than the dimer
have been identified in yeast mitochondria using BN-PAGE,
[7,12] but also in mammalian mitochondria where minor bands
of oligomeric ATP synthase often were detectable but not
explicitly mentioned. Since the combination of neutral deter-
gent and negatively charged Coomassie-dye in BN-PAGE can
potentially dissociate oligomeric ATP synthase into dimeric
and monomeric forms, we applied clear-native PAGE (CN-
PAGE [13]) for separation of membrane protein complexes. This
technique uses the same cathode and anode buffers as BN-PAGE
except that no Coomassie-dye is added to samples and buffers.
CN-PAGE is a very useful separation technique whenever Coo-
massie-dye interferes with techniques required to further analyze
the native complexes, e.g., determination of in-gel catalytic activ-
ities [13,14] or efficient microscale separation of membrane
protein complexes for fluorescence resonance energy transfer
(FRET) analyses [15]. As demonstrated in Fig. 1, in particular,
the combination of digitonin and CN-PAGE can better retain
labile supramolecular assemblies of membrane protein com-
plexes that usually are dissociated under the conditions of BN-
PAGE. Rat heart mitochondrial sediments were dissolved with
digitonin and identical samples were then applied to BN-PAGE
(Fig. 1a) and CN-PAGE (Fig. 1b). Direct comparison of the two
gels revealed that the resolution of BN-PAGEwas considerably
higher compared to CN-PAGE, as judged from the sharpness of
bands for individual respiratory complexes and supercomplexes
(assigned 0, 1, 2 in Fig. 1a). However, tetrameric and hexameric
complex V (VT and VH) were hardly detectable in BN-gels (for
molecular mass calibration and assignment of oligomeric states of
complex V see ref. [13]). The observation of higher amounts of
tetrameric and hexameric complex V in CN-gels (VT and VH in
Fig. 1b) seemed no strong argument in favor of a physiological
oligomeric state of complex V, since protein complexes that are
applied as dilute samples for CN-PAGE become highly concen-
trated protein bands within the sample wells and may aggregate
[13]. In contrast to BN-PAGE, no annulus of negative Coomassie-
dye charges around the complexes can protect against protein
aggregation. Therefore, artificial association of membrane protein
complexes during CN-PAGE cannot be excluded [13]. Reducing
the digitonin amounts for membrane solubilization to 25% of the
amounts used for Fig. 1a, b had no severe effect on the amount of
solubilized complex V (Fig. 1c, d). Under these low digitonin
conditions oligomeric complex V was also observed following
BN-PAGE which supports the view that ATP synthase forms
oligomeric structures in the membrane. According to our recent
analysis of masses and oligomeric states of complex V [13], only
even numbered complexVoligomers exist in reasonable amounts.
This is in contrast to another analysis of mammalian tissues that
assigns a trimeric state to a highly abundant form of complex V
[16].
2.2. Catalytic activity of various oligomeric states of ATP
synthase
Using chromatographic techniques and mild non-ionic deter-
gents like dodecylmaltoside or Triton X-100, the mitochondrial
Fig. 1. Two-dimensional separation of oligomeric ATP synthase from rat heart mitochondria using 1-D native electrophoretic techniques and 2-D SDS-PAGE. (a)
Solubilization by standard digitonin amounts and separation by BN-PAGE. (b) Solubilization by standard digitonin amounts and separation by CN-PAGE. (c and d)
Similar to a and b, but using low digitonin (25% of the standard amounts used in a and b). I, III, IV, respiratory complexes I, III, and IV; VM, VD, VT, VH, monomeric,
dimeric, tetrameric, and hexameric complex V, respectively; (0, 1, 2), respiratory supercomplexes containing monomeric complex I, dimeric complex III, and zero (0),
or one (1), or two (2) copies of complex IV. Subunit b (b) and the α, β, and γ subunits of ATP synthase (complex V) are assigned.
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isolated in monomeric form. Using digitonin for solubilization,
dimeric or higher oligomeric ATP synthase seemed to be pre-
served in the first purification steps but all attempts to further
purify dimeric or oligomeric ATP synthase failed (Schägger, H.,
unpublished). An isolation technique that separates various olig-
omeric forms like BN-PAGE therefore was highly welcome. Un-
fortunately, the in-gel ATP hydrolysis activity of complex Vin BN-
gels was so low [14,17] that overnight incubation in the slightly
alkaline assay buffer was required to visualize the ATPase activity
of complex V by the appearance of a white lead phosphate pre-
cipitate. Another important disadvantage of the ATPase assay in
BN-gels was the insensitivity towards the inhibitor oligomycin so
that it remained unclear whether the observed low rate of ATPase
activity corresponded to complex V activity or rather reflected
ATPase activity of free F1-domains that continuously dissociate
from holo-complex V in the presence of Coomassie-dye at slightly
alkaline pH. Regarding these disadvantages of BN-PAGE, it was a
major progress when digitonin andCN-PAGE could be used for in-
gel separation ofmonomeric and dimeric yeast ATP synthase, since
the ATPase assay in CN-gels was at least 10 times faster than in
BN-gels and fully oligomycin-sensitive, indicating that only holo-
ATPase and not dissociated F1-domains was analyzed [14]. Using
digitonin and CN-PAGE, the oligomycin-sensitive catalytic activ-
ities of monomeric and dimeric ATP synthase were comparable
[13]. This strongly suggested that the physiological ATP synthase
activity is not regulated by monomer/dimer dynamics of ATP
synthase. Furthermore, formation of the yeast ATP synthase dimerdid not require the ATPase inhibitor protein INH1. This has been
demonstrated using BN-PAGE for the separation of complex V
monomers and dimers and ATPase activity measurement in iso-
lated mitochondria [18]. How can these data suggesting a per-
manent inhibitor protein independent dimeric state be reconciled
with the data of Cabezon et al. [19,20] who showed that the natural
IF1 inhibitor protein of bovine ATP synthase can induce dimer-
ization of monomeric F1-domains? Of course, it seems tempting to
speculate that IF1, a homologue of yeast INH1, might be involved
also in dimerization of holo-ATP synthase thereby potentially reg-
ulating catalytic activity. Are there major structural and functional
differences between yeast and mammalian ATP synthase? To our
knowledge, there is only one report suggesting that there might be
in fact a major functional difference between yeast and bovine ATP
synthase. Tomasetig et al. [21] reported that, in contrast to the
monomeric state, dimeric complex V from bovine mitochondria is
inactive, and that this inactive dimeric state is independent of the
degree of IF1 binding. However, our functional analyses of various
oligomeric states of rat heart complex V indicated that the specific
activities of monomeric, dimeric, tetrameric, hexameric and octa-
meric complex V were comparable and oligomycin-sensitive [13].
Yeast INH1 and mammalian IF1 inhibitor proteins usually are
partly removed from their binding sites on monomeric and dimeric
ATP synthase during BN-PAGE [18,22]. However, IF1-binding to
higher oligomeric states of mammalian ATP synthase has not yet
been analyzed. Substoichiometric binding of inhibitor protein to
these oligomers exhibiting uniform catalytic activities would sug-
gest that formation of large supramolecular structures from ATP
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synthase activity. However, in spite of that, the cells' metabolic
state, generation and loss of mitochondrial cristae, and shrinking
and swelling of mitochondria may correlate with formation and
disintegration of supramolecular ATP synthase structures.
3. Monomer/monomer and dimer/dimer interfaces
Two subunits of yeast ATP synthase, subunits e and g, have
initially been suggested to be essential for the formation of di-
meric ATP synthase, since the dimer could not be detected fol-
lowingBN-PAGE upon deletion of either one of the two genes for
subunits g and e [4]. Later, some experimental evidence suggested
that subunits g and e might not be essential for formation but for
stabilization of the dimer so that it can be isolated by BN-PAGE
using either low Triton X-100 or relatively high digitonin for
solubilization [4,5]. Subunits g and e have also been proposed to
be important for the generation of cristae morphology [7,12]
although lack of these subunits does still allow close neighborship
of two ATP synthase monomers in the membrane. This became
apparent fromFRETanalyses using subunit b-GFP and subunit b-
BFP fusions to demonstrate direct physical interactions of two
monomers in membranes of subunit e deletion mutants [23].
Direct physical interactions of two monomers via subunit b have
also been shown by crosslinking of two ATP synthase monomers
in the membranes of the parental yeast strain [24] and subunit e or
subunit g deletion strains [7]. Also, crosslinking of two ATP
synthase monomers via subunit i has been observed in yeast
mitochondrial membranes [25].
Subunits e and g have clearly been identified as the major
dimer-stabilizing subunits in the monomer/monomer interface
[4,12,26–28]. Since not only dimeric but also oligomeric states of
yeast ATP synthase have been observed [7,12,13,16], it has been
suggested that crosslinks involving subunit b and/or i might not
play a role for the monomer/monomer interactions in the initial
dimer but for the dimer/dimer interactions in oligomeric ATP
synthase [7,23–25]. Although the number and identity of all
protein subunits involved in the monomer/monomer interface is
not exactly known, it seems clear that at least subunits e and g are
directly involved in linking the membrane domains of the two
monomers together [4,12,26–28]. Both subunits cooperate to sta-
bilize the detergent-sensitive interaction of two membrane do-
mains under the conditions of BN-PAGE using digitonin or low
Triton X-100. The view that the hydrophobic domains are in-
volved in the monomer/monomer interface is also supported by
two recent electron microscopic single particle analyses of dimeric
ATP synthase from bovine heart mitochondria and from mito-
chondria of the alga Polytomella [29,30]. In both cases, the ATP
synthase monomers were linked via FO-domains that joined at an
angle of about 40o [29] or about 70 ° [30], respectively, to form
conical structures. Surprisingly, a second stalkwas not identified in
the bovine structure showing closely opposed F1-domains, where-
as it was clearly observed in the Polytomella structure where the
F1-domains were completely separated. May this indicate that the
two structures are views from different sides? Is the interface seen
in the Polytomella structure the one that we called the monomer/
monomer interface in the initial dimer? Does the bovine structure,in contrast, exhibit the dimer/dimer interface? It should be noted
here that the bovine and the algal ATP synthase as well, have not
been analyzed following native extraction of the complexes from
BN-gels, as the presentation of BN-gels might suggest [29,30], but
immediately following the isolation with density gradients, i.e., in
the presence of detergents but in the absence of Coomassie-dye.
Therefore, it seems possible that dimeric structures with different
interfaces, abbreviated as monomer/monomer and dimer/dimer
interfaces, have been isolated by the density gradients and analyzed
by electron microscopy. Control BN-gels that indicate dimers in
both papers [29,30] presumably cannot discern how the two
monomers are associated, since all experience with BN-PAGE
suggests that BN-PAGE does not dissociate supramolecular struc-
tures if samples are applied with detergent concentrations close to
the critical micelle concentration.
The interface between F1-domains in the bovine structure
seems especially interesting, since the IF1 inhibitor protein is
potentially bridging the two hydrophilic domains [29]. Other
candidates for the dimer/dimer interface are subunits b and i.
Instead, these two proteins may reside in the vicinity of subunits
e and g thus contributing to the monomer/monomer interaction.
4. Subcomplexes of ATP synthase
Following discussion of oligomeric and dimeric ATP synthase
and their potential interfaceswewill now focus on selected aspects
of assembly and disassembly of monomeric ATP synthase.
4.1. Biochemical analysis of F1-subcomplexes
We used human rho zero cells [31] that contain mitochondria
but lack mitochondrial DNA to search for the largest sub-
complex of ATP synthase that is assembled in the absence of the
two genes for the mitochondrially encoded subunits ATP6 and
ATP8 that are also named subunits a and A6L [22]. Using BN-
PAGE we identified three types of F1-subcomplexes: (1) F1
catalytic domain (F1 x; mass around 370 kDa) containing sub-
units α, β, γ, δ, and ε, (2) F1 catalytic domain with bound
inhibitor protein IF1 (F1 y; mass around 400 kDa), and (3) F1-c
subcomplex, i.e., F1 catalytic domain with bound ring of c-
subunits and bound inhibitor protein IF1 (F1 z; mass around
470 kDa). We conclude that F1-c subcomplex is a rather stable
assembly intermediate or dead-end result of aborted complex V
assembly in mammalian mitochondria [22]. In fact, subunit c
had been identified as the first FO-subunit that associates with
the F1-domain during assembly of yeast and Escherichia coli
ATP synthase [32–34]. This interaction between an oligomeric ring
of subunits c and soluble F1-domain generates a rather stable F1-c
subcomplex. In yeast, this subcomplexwas isolated by dissociation
of other subunits from holo-ATP synthase and crystallized [35].
In order to compare specific ATP hydrolysis activities, we used
in-gel ATPase assays and estimated complexV protein amounts by
Coomassie-staining or Western blots [22]. The smallest F1 sub-
complex (F1 x) not containing bound IF1 inhibitor showed highest
specific ATPase activity. Corresponding lead phosphate precipi-
tates for the smallest F1 subcomplex were detectable after 1 h
incubation in assay bufferwhereas overnight extension of the assay
Fig. 2. Identification of three different F1-subcomplexes of mitochondrial ATP
synthase in a mitochondrial encephalomyopathy patient with unknown genetic
defect. MDS and EFG1 deficiency have been excluded. Ten-milligram skeletal
muscle of the patient was used to separate the native oxidative phosphorylation
complexes by 1-D BN-PAGE and the subunits by 2-D Tricine-SDS-PAGE. II,
III, IV, V, complexes II, III, IV, and V. The masses of complex II subunits are
assigned. Indicators for a mitochondrial disorder are: (i) the absence of
detectable amounts of complex I, and (ii) the accumulation of three types of F1-
subcomplexes (z, y, x, yellow arrows). All three F1-subcomplexes contain F1-
subunits α, β, γ, δ, and ε, as indicated. F1-subcomplexes y and z contain also
bound inhibitor protein (IF1). F1-subcomplex z contains a ring of c-subunits in
addition (immunoblot not shown). This F1-subcomplex (470 kDa) is almost as
large as the neighboring complex III (500 kDa).
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ATPase activity for F1 subcomplexes y and z, in spite of the
presence of bound inhibitor protein, is explained by the extended
overnight incubation in slightly alkaline buffer and a presumed
continuous dissociation of IF1-inhibitor protein [22]. We conclude
that IF1 inhibitor protein (in unknown state of oligomerization) can
inhibit monomeric F1-subcomplex and does not require dimeriza-
tion of F1-domains. Thus, dimerization of F1-domains and inhibi-
tion of F1-domains by IF1 inhibitor protein are independent effects.
4.2. Subcomplexes of human ATP synthase mark mitochondrial
biosynthesis disorders
To analyze whether deficiency of mtDNA encoded subunits
had similar effects in human mitochondrial disorders, we used
biopsy samples of patients with mtDNA depletion syndrome
(MDS [36–40]) which is a phenotypically heterogeneous group
of disorders characterized by reduced but, in contrast to rho zero
cells, not completely missing mtDNA. Furthermore, we used
biopsy samples of patients with other mitochondrial biosynthe-
sis disorders such as neurogenic muscle weakness, ataxia, and
retinitis pigmentosa (NARP) and maternally inherited Leigh's
syndrome (MILS) that are associated with mutations in one of
the two mitochondrial genes of ATP synthase, namely, the ATP6
gene coding for subunit 6, also named subunit a [41–43].
Not surprisingly, we observed large amounts of three types of
F1-subcomplexes also inMDS and NARP/MILS patients, and in
biopsy samples of patients with unknown genetic defects, as
shown in Fig. 2, but not in patients with a variety of different
mitochondrial tRNA mutations. By quantifying the F1-subcom-
plexes and also the other oxidative phosphorylation complexes
in parallel, we were able to discriminate different classes of
defects of mitochondrial biosynthesis, as described in detail [22].
Briefly: Class 1 comprises NARP/MILS syndromes that are
characterized by accumulating F1-subcomplexes, whereas the
other mitochondrial complexes are normal. Class 2 comprises
MDS syndromes that are associated with accumulating F1-
subcomplexes and reduced amounts of complexes I and IV.
Class 3 comprises tRNA mutations like mitochondrial encepha-
lomyopathy with lactic acidosis and stroke-like symptoms
(MELAS) ormyoclonus epilepsywith ragged red fibers (MERRF)
that are characterized by reduced amounts of complexes I and IV,
as with MDS. However, the amounts of F1-subcomplexes are
negligible. Class 4 comprises EFG1 deficiency and deficiencies of
other factors involved in mitochondrial translation. The patterns of
oxidative phosphorylation complexes in EFG1 deficiency seem to
be similar to MDS but complex III is also reduced. This has been
deduced from one-dimensional BN-gels in the work of Coenen et
al. [44] but a two-dimensional electrophoretic analysis is still
missing. Other so far unknown genetic alterations, potentially in
one of the numerous factors involved in mitochondrial translation
[45], are expected to produce similar two-dimensional protein
patterns of oxidative phosphorylation complexes, as summarized
above for EFG1 deficiency or MDS. An example for one patient
who had normal mtDNA content and no genetic alteration of
EFG1 is shown in Fig. 2. This type of mitochondrial biosynthesis
disorder seems not to be rare, since we observed similar two-dimensional protein patterns in about 5% of all patients with
mitochondrial encephalomyopathies that we had analyzed. De-
spite of some unsolved problems, the suggested electrophoretic
approach currently seems to be the most straightforward approach
to localize established and novel defects in genes for oxidative
phosphorylation complexes and factors required formitochondrial
biosynthesis.
5. Respiratory string model
In the pioneering electron microscopic analyses of Allen et al.
[1], not only 9-nm projections from the inner mitochondrial mem-
brane, the F1 headpieces of ATP synthase, had been observed but
also larger 13×22-nm projections that tentatively were assigned as
complex I dimers, since complex I is the only oxidative phos-
phorylation complex that is larger than ATP synthase. These large
particles were clearly viewed at intervals of 26–30 nm, and seem to
wind as a helical band around the tubular cristae, similar to the
helical F1 band. In many cases, the large projections appeared to be
subdivided by a cleft suggesting that each elongated projection is
composed of two monomers. Also the ratio of the 13×22-nm and
9-nm projections, the presumed representatives of complex I
dimers and ATP synthase, is compatible with the expected ratio of
the two complexes. Comparing the number of the 13×22-nm and
9-nm projections, a ratio of 18 complex I dimers per 75 ATP
synthase dimers was estimated which is in the same order as the
1:3 ratio of complexes I and V determined for bovine heart
mitochondria [46]. However, an explanation for the regular
Fig. 3. Model for a linear association of respiratory chain supercomplexes in mammalian mitochondria. Solubilization properties of yeast and bovine mitochondria
using low Triton X-100 suggested that respiratory chain supercomplexes interact to form larger supramolecular structures. This "respiratory string" model can explain
the regular 26–30 nm intervals (dashed black lines) of the large 13×22-nm projections and the cleft dissecting the 13×22-nm particles as observed with Paramecium
mitochondria [1]. It is in accordance with (i) the isolation of large I1III2IV4 and smaller III2IV4 respiratory supercomplexes (separated by dashed blue lines), (ii) the
determined ratio of respiratory complexes I:III:IV that is 1:3:6 in bovine heart [46], and (iii) the observation of tetrameric bovine complex IV. Flavoprotein-dependent
dehydrogenases may interact directly with the central III2IV4 supercomplex or indirectly via the quinone pool.
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this pioneering work.
In the light of new evidence for the existence of respiratory
chain supercomplexes or respirasomes [5,47], it is tempting to
speculate that the 13×22-nm projections do not represent
complex I dimers but represent respirasomes containing complex
I. The regular intervals could originate from linearly associated
complexes III and IV to which complex I is bound at specific sites
as depicted in Fig. 3. This model for a linear association of
respiratory chain supercomplexes is supported by two other pre-
viously reported lines of evidence: (1) Respiratory complex II
(succinate:ubiquinone reductase) and mitochondrial complex V
(ATP synthase) can be selectively and almost quantitatively
solubilized from yeast or bovine heart mitochondria using low
amounts of Triton X-100 [4,48]. This indicates that a certain
detergent/protein ratio is sufficient to solubilize lipid areas bet-
ween mitochondrial complexes, thereby dissolving complexes II
and Valmost quantitatively, and even dissociating dimeric bovine
ATP synthase into the monomers. In contrast, respiratory super-
complexes are not dissolved suggesting that the supercomplexes
remain associated as huge structures that are only broken and
solubilized if increasing amounts or more aggressive detergents
are used. (2) Bovine complex IV can tetramerize under certain
conditions.Whenwe used preparative BN-PAGE to further purify
complex IV from bovine heart that was isolated chromatogra-
phically using Triton X-100, we could observe a major band of
tetrameric complex IV in addition to minor bands of monomeric
and dimeric complex IV (Schägger, H., unpublished data). We
therefore suggest that respirasomes associate specifically by te-
tramerization of complex IV thus generating “respiratory strings”,
i.e. linear assemblies of respiratory supercomplexes. The asso-
ciation of two “complete” respirasomes, i.e., I1III2IV4 supercom-
plexes containing monomeric complex I, dimeric complex III,
and two copies of dimeric complex IV, as shown in Fig. 3, is
consistent with the cleft dissecting the 13×22-nm particles that
has been observed in electron microscopic studies [1]. In accor-
dance with the determined ratio of respiratory complexes I:III:IV
which is 1:3:6 in bovine heart mitochondria, we postulated thatthe respiratory chain consists of interconnected I1III2IV4 and
III2IV4 supercomplexes in a 2:1 ratio [46]. Alternating connection
of one copy of the III2IV4 supercomplex and dimeric I1III2IV4
supercomplex as depicted in Fig. 3 can explain the regular 26–30-
nm intervals of the 13×22-nm projections.
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